Vermilion Behavioral Health Systems | |
2520 N University Avenue, Lafayette, Louisiana 70507 | |
(337) 234-5614 | |
Not Available |
Name | Vermilion Behavioral Health Systems |
---|---|
Type | Psychiatric Hospital |
Location | 2520 N University Avenue, Lafayette, Louisiana |
Ownership | Proprietary |
Emergency Services | No |
Medicare ID (CCN) | 194044 |
NPI Number | 1114983053 |
Organization Name | VERMILION HOSPITAL , INC |
Doing Business As | VERMILION HOSPITAL FOR PSYCHIATRIC AND ADDICTIVE MEDICINE |
Address | 2520 N University Ave, Lafayette, LA 70507 |
Hospital Type | Psychiatric Hospital |
Phone Number | 337-234-5614 |
News Archive
Family doctors and psychiatrists should carefully monitor the heart health of patients with anxiety disorders, Dr. Simon Bacon told the Canadian Cardiovascular Congress 2008, co-hosted by the Heart and Stroke Foundation and the Canadian Cardiovascular Society. "People with anxiety disorders are four times more likely to develop high blood pressure (hypertension) over one year than those of us who are anxiety free," says Dr. Bacon, a Heart and Stroke Foundation researcher at the Montreal Heart Institute. "Hypertension is a leading risk factor for stroke and heart disease."
More than 1 in 10 people with a range of non-cancerous lung diseases may be sick as a result of inhaling vapors, gas, dust or fumes at work, according to a joint American Thoracic Society and the European Respiratory Society statement published in the ATS's American Journal of Respiratory and Critical Care Medicine.
Mother Nature's best efforts to protect growing bones come up short when girls' diets contain too little calcium, according to a study at the USDA Children's Nutrition Research Center at Baylor College of Medicine in Houston.
When Jeanne Anderson was diagnosed with breast cancer three years ago, the Beverly Hills resident underwent a course of chemotherapy to shrink the tumors in preparation for surgery.
Idenix Pharmaceuticals, Inc., a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced the pricing of an underwritten offering of 6,460,672 shares of its common stock at a price of $4.35 per share. After the underwriting discount and estimated offering expenses payable by the company, the company expects to receive net proceeds of approximately $26.2 million. All of the shares are being sold by Idenix.
› Verified 6 days ago
NPI Number | 1619437522 |
Organization Name | LUKE LEONARDS APRN |
Doing Business As | LUKE LEONARDS APRN |
Address | 2520 N University Ave, Lafayette, LA 70507 |
Hospital Type | Psychiatric Hospital |
Phone Number | 337-806-8934 |
News Archive
Family doctors and psychiatrists should carefully monitor the heart health of patients with anxiety disorders, Dr. Simon Bacon told the Canadian Cardiovascular Congress 2008, co-hosted by the Heart and Stroke Foundation and the Canadian Cardiovascular Society. "People with anxiety disorders are four times more likely to develop high blood pressure (hypertension) over one year than those of us who are anxiety free," says Dr. Bacon, a Heart and Stroke Foundation researcher at the Montreal Heart Institute. "Hypertension is a leading risk factor for stroke and heart disease."
More than 1 in 10 people with a range of non-cancerous lung diseases may be sick as a result of inhaling vapors, gas, dust or fumes at work, according to a joint American Thoracic Society and the European Respiratory Society statement published in the ATS's American Journal of Respiratory and Critical Care Medicine.
Mother Nature's best efforts to protect growing bones come up short when girls' diets contain too little calcium, according to a study at the USDA Children's Nutrition Research Center at Baylor College of Medicine in Houston.
When Jeanne Anderson was diagnosed with breast cancer three years ago, the Beverly Hills resident underwent a course of chemotherapy to shrink the tumors in preparation for surgery.
Idenix Pharmaceuticals, Inc., a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced the pricing of an underwritten offering of 6,460,672 shares of its common stock at a price of $4.35 per share. After the underwriting discount and estimated offering expenses payable by the company, the company expects to receive net proceeds of approximately $26.2 million. All of the shares are being sold by Idenix.
› Verified 6 days ago
NPI Number | 1821024563 |
Organization Name | VERMILION HOSPITAL LLC |
Doing Business As | VERMILION BEHAVIORAL HEALTH SYSTEMS |
Address | 2520 N. University Ave, Lafayette, LA 70507 |
Hospital Type | Psychiatric Hospital |
Phone Number | 337-234-5614 |
News Archive
Family doctors and psychiatrists should carefully monitor the heart health of patients with anxiety disorders, Dr. Simon Bacon told the Canadian Cardiovascular Congress 2008, co-hosted by the Heart and Stroke Foundation and the Canadian Cardiovascular Society. "People with anxiety disorders are four times more likely to develop high blood pressure (hypertension) over one year than those of us who are anxiety free," says Dr. Bacon, a Heart and Stroke Foundation researcher at the Montreal Heart Institute. "Hypertension is a leading risk factor for stroke and heart disease."
More than 1 in 10 people with a range of non-cancerous lung diseases may be sick as a result of inhaling vapors, gas, dust or fumes at work, according to a joint American Thoracic Society and the European Respiratory Society statement published in the ATS's American Journal of Respiratory and Critical Care Medicine.
Mother Nature's best efforts to protect growing bones come up short when girls' diets contain too little calcium, according to a study at the USDA Children's Nutrition Research Center at Baylor College of Medicine in Houston.
When Jeanne Anderson was diagnosed with breast cancer three years ago, the Beverly Hills resident underwent a course of chemotherapy to shrink the tumors in preparation for surgery.
Idenix Pharmaceuticals, Inc., a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced the pricing of an underwritten offering of 6,460,672 shares of its common stock at a price of $4.35 per share. After the underwriting discount and estimated offering expenses payable by the company, the company expects to receive net proceeds of approximately $26.2 million. All of the shares are being sold by Idenix.
› Verified 6 days ago
NPI Number | 1952649147 |
Organization Name | VERMILION HOSPITAL, LLC |
Doing Business As | OPTIMA SPECIALTY HOSPITAL |
Address | 1131 Rue Du Belier, Lafayette, LA 70506 |
Hospital Type | Psychiatric Hospital |
Phone Number | 337-991-0571 |
News Archive
Family doctors and psychiatrists should carefully monitor the heart health of patients with anxiety disorders, Dr. Simon Bacon told the Canadian Cardiovascular Congress 2008, co-hosted by the Heart and Stroke Foundation and the Canadian Cardiovascular Society. "People with anxiety disorders are four times more likely to develop high blood pressure (hypertension) over one year than those of us who are anxiety free," says Dr. Bacon, a Heart and Stroke Foundation researcher at the Montreal Heart Institute. "Hypertension is a leading risk factor for stroke and heart disease."
More than 1 in 10 people with a range of non-cancerous lung diseases may be sick as a result of inhaling vapors, gas, dust or fumes at work, according to a joint American Thoracic Society and the European Respiratory Society statement published in the ATS's American Journal of Respiratory and Critical Care Medicine.
Mother Nature's best efforts to protect growing bones come up short when girls' diets contain too little calcium, according to a study at the USDA Children's Nutrition Research Center at Baylor College of Medicine in Houston.
When Jeanne Anderson was diagnosed with breast cancer three years ago, the Beverly Hills resident underwent a course of chemotherapy to shrink the tumors in preparation for surgery.
Idenix Pharmaceuticals, Inc., a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced the pricing of an underwritten offering of 6,460,672 shares of its common stock at a price of $4.35 per share. After the underwriting discount and estimated offering expenses payable by the company, the company expects to receive net proceeds of approximately $26.2 million. All of the shares are being sold by Idenix.
› Verified 6 days ago
News Archive
Family doctors and psychiatrists should carefully monitor the heart health of patients with anxiety disorders, Dr. Simon Bacon told the Canadian Cardiovascular Congress 2008, co-hosted by the Heart and Stroke Foundation and the Canadian Cardiovascular Society. "People with anxiety disorders are four times more likely to develop high blood pressure (hypertension) over one year than those of us who are anxiety free," says Dr. Bacon, a Heart and Stroke Foundation researcher at the Montreal Heart Institute. "Hypertension is a leading risk factor for stroke and heart disease."
More than 1 in 10 people with a range of non-cancerous lung diseases may be sick as a result of inhaling vapors, gas, dust or fumes at work, according to a joint American Thoracic Society and the European Respiratory Society statement published in the ATS's American Journal of Respiratory and Critical Care Medicine.
Mother Nature's best efforts to protect growing bones come up short when girls' diets contain too little calcium, according to a study at the USDA Children's Nutrition Research Center at Baylor College of Medicine in Houston.
When Jeanne Anderson was diagnosed with breast cancer three years ago, the Beverly Hills resident underwent a course of chemotherapy to shrink the tumors in preparation for surgery.
Idenix Pharmaceuticals, Inc., a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced the pricing of an underwritten offering of 6,460,672 shares of its common stock at a price of $4.35 per share. After the underwriting discount and estimated offering expenses payable by the company, the company expects to receive net proceeds of approximately $26.2 million. All of the shares are being sold by Idenix.
› Verified 6 days ago
Lafayette General Medical Center Acute Care Hospital Location: 1214 Coolidge Avenue, Lafayette, Louisiana 70503 Phone: (337) 289-7991 | |
University Hospital & Clinics Acute Care Hospital Location: 2390 West Congress, Lafayette, Louisiana 70506 Phone: (337) 261-6000 | |
Our Lady Of Lourdes Regional Medical Center, Inc Acute Care Hospital Location: 4801 Ambassador Caffery Parkway, Lafayette, Louisiana 70508 Phone: (337) 470-2100 | |
Park Place Surgical Hospital Acute Care Hospital Location: 4811 Ambassador Caffery Parkway, Lafayette, Louisiana 70508 Phone: (337) 237-8119 | |
Lafayette Surgical Specialty Hospital Acute Care Hospital Location: 1101 Kaliste Saloom Rd, Lafayette, Louisiana 70508 Phone: (337) 769-4100 | |
Vermilion Behavioral Health Systems Psychiatric Hospital Location: 2520 N University Avenue, Lafayette, Louisiana 70507 Phone: (337) 234-5614 |